-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
STOCKHOLDER ALERT: The M&A Class Action Firm Continues the Investigation of the Merger - USX, OSH, TESS, CHRA, STSA
STOCKHOLDER ALERT: The M&A Class Action Firm Continues the Investigation of the Merger - USX, OSH, TESS, CHRA, STSA
NEW YORK, April 28, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
- U.S. Xpress Enterprises, Inc. (NYSE: USX), relating to its proposed sale to Knight-Swift Transportation Holdings Inc. Under the terms of the agreement, USX shareholders are expected to receive $6.15 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Oak Street Health, Inc. (NYSE: OSH), relating to its proposed sale to CVS Health. Under the terms of the agreement, OSH shareholders are expected to receive $39.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- TESSCO Technologies Inc. (NASDAQ: TESS), relating to its proposed sale to affiliates of Lee Equity Partners and Twin Point Capital. Under the terms of the agreement, TESS shareholders are expected to receive $9.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Charah Solutions, Inc. (OTC: CHRA), relating to its proposed sale to SER Capital Partners/ Under the terms of the agreement, CHRA shareholders are expected to receive $6.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
We are a national class action securities and consumer litigation law firm that has recovered millions of dollars for shareholders and is committed to protecting investors and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2020 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, over the years the firm has recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2023 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (). Prior results do not guarantee a similar outcome with respect to any future matter.
SOURCE Monteverde & Associates PC
NEW YORK, April 28, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
纽约, 2023年4月28日 /PRNewswire/ — 胡安·蒙特维德,集体诉讼公司Monteverde & Associates PC(“并购集体诉讼公司”)的创始人兼管理合伙人,该公司被评为全国性证券公司 前 50 名 在 2018-2021 年 ISS 证券集体诉讼服务报告中,总部位于 帝国大厦 在 纽约市,正在调查:
-
U.S. Xpress Enterprises, Inc. (NYSE: USX), relating to its proposed sale to Knight-Swift Transportation Holdings Inc. Under the terms of the agreement, USX shareholders are expected to receive $6.15 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
Oak Street Health, Inc. (NYSE: OSH), relating to its proposed sale to CVS Health. Under the terms of the agreement, OSH shareholders are expected to receive $39.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
TESSCO Technologies Inc. (NASDAQ: TESS), relating to its proposed sale to affiliates of Lee Equity Partners and Twin Point Capital. Under the terms of the agreement, TESS shareholders are expected to receive $9.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
Charah Solutions, Inc. (OTC: CHRA), relating to its proposed sale to SER Capital Partners/ Under the terms of the agreement, CHRA shareholders are expected to receive $6.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
美国 Xpress 企业有限公司 (纽约证券交易所:USX),与其出售给奈特-斯威夫特运输控股公司的提议有关。根据协议条款,预计美国证券交易所股东将获得 6.15 美元 他们拥有的每股现金。 点击这里了解更多信息: 它是免费的,您无需支付任何费用或义务。
-
橡树街健康有限公司 (纽约证券交易所:OSH),与其出售给CVS Health的提议有关。根据协议条款,预计职业安全与健康股东将获得 39.00 美元 他们拥有的每股现金。 点击这里了解更多信息: 它是免费的,您无需支付任何费用或义务。
-
乐购科技公司 (纳斯达克股票代码:TESS),涉及其向Lee Equity Partners和Twin Point Capital的关联公司出售根据协议条款,预计TESS股东将获得 9.00 美元 他们拥有的每股现金。 点击这里了解更多信息: 它是免费的,您无需支付任何费用或义务。
-
Charah Solutions, Inc (场外交易时间:CHRA),与其向SER Capital Partners出售的提议有关/根据协议条款,CHRA股东预计将获得 6.00 美元 他们拥有的每股现金。 点击这里了解更多信息: 它是免费的,您无需支付任何费用或义务。
- 萨摩制药株式会社 (纳斯达克股票代码:STSA),与其向新日本生物医学实验室有限公司出售的提议有关。根据协议条款,预计STSA股东将获得一份最多可交易的CVR 5.77 美元 现金 plus 0.91 美元 他们拥有的每股现金。 点击这里了解更多信息: 它是免费的,您无需支付任何费用或义务。
About Monteverde & Associates PC
关于 Monteverde & Ass
We are a national class action securities and consumer litigation law firm that has recovered millions of dollars for shareholders and is committed to protecting investors and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2020 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, over the years the firm has recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.
我们是一家全国性的集体诉讼、证券和消费者诉讼律师事务所 已经收回了数百万美元 对于股东和 是 致力于保护投资者 以及消费者因企业不当行为而受害。Monteverde & Associates的律师在提起并购和证券集体诉讼诉讼方面拥有丰富的经验,他们通过追回资金和纠正公司不当行为来保护投资者。领导该事务所的蒙特维德先生在2013年和2017-2019年被《超级律师》评为证券诉讼的后起之秀,该奖项授予特定领域的不到2.5%的律师。他还被选中 马丁代尔-哈贝尔是2017-2020年最受好评的律师。我们公司最近的成功包括修改法律,这是一项重大胜利,降低了第九巡回法院《交易法》第14(e)条规定的责任标准。此后,我们公司成功地维护了这一胜利,撤销了美国最高法院临时批准的移审令。 Emulex Corp. 诉 Varjabedian,139 S. Ct. 1407 (2019)。此外,多年来,该公司在并购集体诉讼案件中为股东追回或担保了十几只现金普通基金。
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
如果您拥有上述任何一家上市公司的普通股并希望获得更多信息并免费保护您的投资,请访问我们的 网站 或者联系 Juan E. Monteverde,Esq 要么通过电子邮件发送 [电子邮件保护] 或者致电 (212) 971-1341。
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
联系人:
Juan E. Monteverde,Esq
MONTEVERDE & SO
帝国大厦
第五大道 350 号4405 套房
纽约,纽约 10118
美利坚合众国
[电子邮件保护]
电话:(212) 971-1341
Attorney Advertising. (C) 2023 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (). Prior results do not guarantee a similar outcome with respect to any future matter.
律师广告。(C) 2023 Monterverde & Associates负责这则广告的律师事务所是 Monteverde & Associates PC ()。先前的结果并不能保证未来任何事项都会有类似的结果。
SOURCE Monteverde & Associates PC
SOURCE Monteverde
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧